ENTITY
BeiGene

BeiGene (6160 HK)

438
Analysis
Health CareChina
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
more
bullishTrip.com Group
21 Aug 2023 07:29

HSCEI Sep23 Index Review/​Flows - Trip.Com (9961) Added, CG Svcs (6098) Deleted; ~2.5% One Way

The Sep 2023 HSCEI rebal is something of a damp squib. Nothing that big. Capping contributes to the BABA sell. And watch for big moves the next few...

Logo
372 Views
Share
21 Aug 2023 07:29

HSI Sep23 Index Review/​Flows - Sinopharm (1099) IN, CoGard (2007) OUT; 100 Names a Loooong Way Off

The Hang Seng Index Sep 2023 review is a little disappointing. The DELETE is obvious. The ADD wasn't so much. And Hang Seng is highly...

Logo
398 Views
Share
bullishTrip.com Group
20 Aug 2023 09:31

HSCEI Index Rebalance: Trip.com (9961 HK) Replaces CG Services (6098 HK)

As expected, Trip.com replaces CG Services in the HSCEI. Beigene fails liquidity and Zhongsheng's float increases. Float and capping changes result...

Logo
620 Views
Share
bullishBeiGene
16 Aug 2023 11:26

Quiddity HSCEI Sep 23 Flow Expectations Update: US$367mn One-Way, Beigene Vs Peers Interesting

I see BeiGene Ltd (6160 HK) as a high conviction ADD and Country Garden Services Holdings (6098 HK) as a high conviction DEL. Separately, I see...

Share
bullishBeiGene
15 Aug 2023 11:22

Quiddity Leaderboard for Hang Seng Index Sep 23: Beigene Vs Peers An Interesting Trade

Hang Seng Index Sep 23 index changes and indicative weights could be published after the close on Friday 18th August 2023. The Hang Seng Index...

Logo
1.3k Views
Share
x